Antibodies to elastin peptides in sera of Belgian Draught horses with chronic progressive lymphoedema

L. Van Brantegem, H. E V De Cock, Verena K Affolter, L. Duchateau, M. K. Hoogewijs, J. Govaere, G. L. Ferraro, R. Ducatelle

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Reasons for performing study: Chronic progressive lymphoedema (CPL) is a recently recognised disease of the lymphatic system characterised by lesions in the skin of the lower legs in several draught horse breeds, including the Belgian Draught hourse. Clinical signs slowly progress and result in severe disfigurement of the limbs. Ideally, supportive treatment should be started early in the disease process. However early diagnosis and monitoring progression of CPL is still a challenge. Hypothesis: Elastin changes, characterised by morphological alterations as well as increased desmosine levels, in the skin of the distal limbs of horses affected with CPL are probably associated with a marked release of elastin degradation products, which elicit production of circulating anti-elastin antibodies (AEAbs) in the serum. An enzyme-linked immunosorbent assay (ELISA) for detection of serum AEAbs may document elastin breakdown. Methods: An ELISA technique was used to evaluate levels of AEAbs in sera of 97 affected Belgian Draught horses that were clinically healthy except for possible skin lesions, associated with CPL in their distal limbs. The horses were divided into 5 groups according to the severity of these skin lesions: normal horses (Group 1, n = 36), horses with mild lesions (Group 2, n = 43), horses with moderate lesions (Group 3, n = 8), horses with severe lesions (Group 4, n = 10) and, as a control, healthy Warmblood horses, unaffected by the disease (Group 5, n = 83). Results: Horses with clinical signs of CPL had significantly higher AEAb levels compared to clinically normal Belgian Draught horses and to healthy Warmblood horses. These levels correlated with severity of lesions. Conclusions: CPL in draught horses is associated with an increase of serum AEAbs. Potential relevance: Evaluation of serum levels of AEAbs by ELISA might be a useful diagnostic aid for CPL. Pathological degradation of elastic fibres, resulting in deficient support of the distal lymphatics, is proposed as a contributing factor for CPL in Belgian Draught horses.

Original languageEnglish (US)
Pages (from-to)418-421
Number of pages4
JournalEquine Veterinary Journal
Volume39
Issue number5
DOIs
StatePublished - Sep 2007

Fingerprint

Belgian (horse breed)
elastin
Lymphedema
Elastin
Horses
peptides
horses
Peptides
antibodies
Antibodies
Serum
Anti-Idiotypic Antibodies
lesions (animal)
skin lesions
limbs (animal)
Skin
Extremities
Enzyme-Linked Immunosorbent Assay
enzyme-linked immunosorbent assay
Desmosine

Keywords

  • Anti-elastin antibodies
  • Belgian Draught horse
  • Chronic progressive lymphoedema
  • ELISA
  • Horse

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Van Brantegem, L., De Cock, H. E. V., Affolter, V. K., Duchateau, L., Hoogewijs, M. K., Govaere, J., ... Ducatelle, R. (2007). Antibodies to elastin peptides in sera of Belgian Draught horses with chronic progressive lymphoedema. Equine Veterinary Journal, 39(5), 418-421. https://doi.org/10.2746/042516407X205888

Antibodies to elastin peptides in sera of Belgian Draught horses with chronic progressive lymphoedema. / Van Brantegem, L.; De Cock, H. E V; Affolter, Verena K; Duchateau, L.; Hoogewijs, M. K.; Govaere, J.; Ferraro, G. L.; Ducatelle, R.

In: Equine Veterinary Journal, Vol. 39, No. 5, 09.2007, p. 418-421.

Research output: Contribution to journalArticle

Van Brantegem, L, De Cock, HEV, Affolter, VK, Duchateau, L, Hoogewijs, MK, Govaere, J, Ferraro, GL & Ducatelle, R 2007, 'Antibodies to elastin peptides in sera of Belgian Draught horses with chronic progressive lymphoedema', Equine Veterinary Journal, vol. 39, no. 5, pp. 418-421. https://doi.org/10.2746/042516407X205888
Van Brantegem, L. ; De Cock, H. E V ; Affolter, Verena K ; Duchateau, L. ; Hoogewijs, M. K. ; Govaere, J. ; Ferraro, G. L. ; Ducatelle, R. / Antibodies to elastin peptides in sera of Belgian Draught horses with chronic progressive lymphoedema. In: Equine Veterinary Journal. 2007 ; Vol. 39, No. 5. pp. 418-421.
@article{de0e267ac9ae4fc0877972d0ac08ece3,
title = "Antibodies to elastin peptides in sera of Belgian Draught horses with chronic progressive lymphoedema",
abstract = "Reasons for performing study: Chronic progressive lymphoedema (CPL) is a recently recognised disease of the lymphatic system characterised by lesions in the skin of the lower legs in several draught horse breeds, including the Belgian Draught hourse. Clinical signs slowly progress and result in severe disfigurement of the limbs. Ideally, supportive treatment should be started early in the disease process. However early diagnosis and monitoring progression of CPL is still a challenge. Hypothesis: Elastin changes, characterised by morphological alterations as well as increased desmosine levels, in the skin of the distal limbs of horses affected with CPL are probably associated with a marked release of elastin degradation products, which elicit production of circulating anti-elastin antibodies (AEAbs) in the serum. An enzyme-linked immunosorbent assay (ELISA) for detection of serum AEAbs may document elastin breakdown. Methods: An ELISA technique was used to evaluate levels of AEAbs in sera of 97 affected Belgian Draught horses that were clinically healthy except for possible skin lesions, associated with CPL in their distal limbs. The horses were divided into 5 groups according to the severity of these skin lesions: normal horses (Group 1, n = 36), horses with mild lesions (Group 2, n = 43), horses with moderate lesions (Group 3, n = 8), horses with severe lesions (Group 4, n = 10) and, as a control, healthy Warmblood horses, unaffected by the disease (Group 5, n = 83). Results: Horses with clinical signs of CPL had significantly higher AEAb levels compared to clinically normal Belgian Draught horses and to healthy Warmblood horses. These levels correlated with severity of lesions. Conclusions: CPL in draught horses is associated with an increase of serum AEAbs. Potential relevance: Evaluation of serum levels of AEAbs by ELISA might be a useful diagnostic aid for CPL. Pathological degradation of elastic fibres, resulting in deficient support of the distal lymphatics, is proposed as a contributing factor for CPL in Belgian Draught horses.",
keywords = "Anti-elastin antibodies, Belgian Draught horse, Chronic progressive lymphoedema, ELISA, Horse",
author = "{Van Brantegem}, L. and {De Cock}, {H. E V} and Affolter, {Verena K} and L. Duchateau and Hoogewijs, {M. K.} and J. Govaere and Ferraro, {G. L.} and R. Ducatelle",
year = "2007",
month = "9",
doi = "10.2746/042516407X205888",
language = "English (US)",
volume = "39",
pages = "418--421",
journal = "Equine veterinary journal. Supplement",
issn = "2042-3306",
publisher = "British Equine Veterinary Association",
number = "5",

}

TY - JOUR

T1 - Antibodies to elastin peptides in sera of Belgian Draught horses with chronic progressive lymphoedema

AU - Van Brantegem, L.

AU - De Cock, H. E V

AU - Affolter, Verena K

AU - Duchateau, L.

AU - Hoogewijs, M. K.

AU - Govaere, J.

AU - Ferraro, G. L.

AU - Ducatelle, R.

PY - 2007/9

Y1 - 2007/9

N2 - Reasons for performing study: Chronic progressive lymphoedema (CPL) is a recently recognised disease of the lymphatic system characterised by lesions in the skin of the lower legs in several draught horse breeds, including the Belgian Draught hourse. Clinical signs slowly progress and result in severe disfigurement of the limbs. Ideally, supportive treatment should be started early in the disease process. However early diagnosis and monitoring progression of CPL is still a challenge. Hypothesis: Elastin changes, characterised by morphological alterations as well as increased desmosine levels, in the skin of the distal limbs of horses affected with CPL are probably associated with a marked release of elastin degradation products, which elicit production of circulating anti-elastin antibodies (AEAbs) in the serum. An enzyme-linked immunosorbent assay (ELISA) for detection of serum AEAbs may document elastin breakdown. Methods: An ELISA technique was used to evaluate levels of AEAbs in sera of 97 affected Belgian Draught horses that were clinically healthy except for possible skin lesions, associated with CPL in their distal limbs. The horses were divided into 5 groups according to the severity of these skin lesions: normal horses (Group 1, n = 36), horses with mild lesions (Group 2, n = 43), horses with moderate lesions (Group 3, n = 8), horses with severe lesions (Group 4, n = 10) and, as a control, healthy Warmblood horses, unaffected by the disease (Group 5, n = 83). Results: Horses with clinical signs of CPL had significantly higher AEAb levels compared to clinically normal Belgian Draught horses and to healthy Warmblood horses. These levels correlated with severity of lesions. Conclusions: CPL in draught horses is associated with an increase of serum AEAbs. Potential relevance: Evaluation of serum levels of AEAbs by ELISA might be a useful diagnostic aid for CPL. Pathological degradation of elastic fibres, resulting in deficient support of the distal lymphatics, is proposed as a contributing factor for CPL in Belgian Draught horses.

AB - Reasons for performing study: Chronic progressive lymphoedema (CPL) is a recently recognised disease of the lymphatic system characterised by lesions in the skin of the lower legs in several draught horse breeds, including the Belgian Draught hourse. Clinical signs slowly progress and result in severe disfigurement of the limbs. Ideally, supportive treatment should be started early in the disease process. However early diagnosis and monitoring progression of CPL is still a challenge. Hypothesis: Elastin changes, characterised by morphological alterations as well as increased desmosine levels, in the skin of the distal limbs of horses affected with CPL are probably associated with a marked release of elastin degradation products, which elicit production of circulating anti-elastin antibodies (AEAbs) in the serum. An enzyme-linked immunosorbent assay (ELISA) for detection of serum AEAbs may document elastin breakdown. Methods: An ELISA technique was used to evaluate levels of AEAbs in sera of 97 affected Belgian Draught horses that were clinically healthy except for possible skin lesions, associated with CPL in their distal limbs. The horses were divided into 5 groups according to the severity of these skin lesions: normal horses (Group 1, n = 36), horses with mild lesions (Group 2, n = 43), horses with moderate lesions (Group 3, n = 8), horses with severe lesions (Group 4, n = 10) and, as a control, healthy Warmblood horses, unaffected by the disease (Group 5, n = 83). Results: Horses with clinical signs of CPL had significantly higher AEAb levels compared to clinically normal Belgian Draught horses and to healthy Warmblood horses. These levels correlated with severity of lesions. Conclusions: CPL in draught horses is associated with an increase of serum AEAbs. Potential relevance: Evaluation of serum levels of AEAbs by ELISA might be a useful diagnostic aid for CPL. Pathological degradation of elastic fibres, resulting in deficient support of the distal lymphatics, is proposed as a contributing factor for CPL in Belgian Draught horses.

KW - Anti-elastin antibodies

KW - Belgian Draught horse

KW - Chronic progressive lymphoedema

KW - ELISA

KW - Horse

UR - http://www.scopus.com/inward/record.url?scp=38449090203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449090203&partnerID=8YFLogxK

U2 - 10.2746/042516407X205888

DO - 10.2746/042516407X205888

M3 - Article

C2 - 17910266

AN - SCOPUS:38449090203

VL - 39

SP - 418

EP - 421

JO - Equine veterinary journal. Supplement

JF - Equine veterinary journal. Supplement

SN - 2042-3306

IS - 5

ER -